Clinical trial J5Q-OX-JRDA - PanKRAS
A Phase 1a/1b Study of the pan-KRAS inhibitor LY4066434 in Participants with KRAS Mutant Solid Tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Lilly |
| EudraCT Identifier | 2024-516733-12-00 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT06607185 |
| Last update |